Colorectal cancer updates from ASCO 2026: Impact of ctDNA and MRD testing on guiding adjuvant chemotherapy and treatment response monitoring

Faculty: John Strickler, MD; Tanios S. Bekaii-Saab, MD
Disclosures

Faculty

VMTB Chair and Speaker

John Strickler, MD
Professor of Medicine
Co-leader, Duke Cancer Institute Molecular Tumor Board
Duke University

Speaker

Tanios S. Bekaii-Saab, MD
David F. and Margaret T. Grohne Professsor of Novel Therapeutics for Cancer Research
Chair and Consultant, Division of Hematology and Medical Oncology
Professor, Mayo Clinic College of Medicine and Science
Mayo Clinic in Arizona

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading